Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Thrombosis × Injections × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 19 Myelodysplastic Syndromes 11 Neoplasms 10 Breast Neoplasms 10 Prostatic Neoplasms 8 Multiple Myeloma 7 Stomach Neoplasms 5 Sarcoma 5 Lung Neoplasms 5 Leukemia, Myelomonocytic, Chronic 5 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Lymphoma, Non-Hodgkin 4 Head and Neck Neoplasms 4 Advanced Solid Tumor 4 Solid Tumor 3 Recurrence 3 Primary Myelofibrosis 3 Myeloproliferative Disorders 3 Mucositis 3 Lymphoma, T-Cell, Peripheral 3 Colorectal Neoplasms 3 Cholangiocarcinoma 3 Carcinoma, Transitional Cell 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Thrombocythemia, Essential 2 Stomatitis 2 Squamous Cell Carcinoma of Head and Neck 2 Skin Neoplasms 2

Interventions

apixaban 3 Warfarin 2 Dalteparin 2 Aspirin 2 fluorescein isothiocyanate-keyhole limpet hemocyanin 1 edoxaban 1 Simvastatin 1 Rivaroxaban 1 Paclitaxel 1 Observation 1 Injections 1 Fondaparinux 1 Enoxaparin 1 Docetaxel 1 Data Collection 1 Dabigatran 1 Clopidogrel 1 Anticoagulants 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05507645 2024-09-05

PUMICE

Beijing Tiantan Hospital

Phase 3 Completed

Ischemic Stroke, Lymphoma, Follicular, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡